Restenosis risk factors after coronary stenting in metabolic syndrome patients
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus. Recently, MS has also been regarded as a pathology enhancing coronary restenosis risk. Certain...
Saved in:
Main Authors: | N. M. Danilov, T. T. Gorgadze, A. P. Savchenko, I. E. Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2007-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01) -
Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01) -
Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy
by: Ziad A. Ali, et al.
Published: (2025-06-01) -
Research advances in the etiology of in-stent restenosis of coronary arteries
by: Hangrui Bai, et al.
Published: (2025-07-01) -
Antioxidant system gene polymorphism and restenosis risk after coronary stenting
by: Yu. A. Shuvalova, et al.
Published: (2008-10-01)